Quarterly Report • May 16, 2022
Quarterly Report
Open in ViewerOpens in native device viewer

Quarterly statement for the period ended March 31, 2022 (Q3 2021/2022)
| Quarterly statement for the | |
|---|---|
| period ended March 31, 2022 |
[in EUR million]
Business report and the Group's position
Consolidated profit and loss account
Consolidated cash flow statement
| Profitability | Q1 2021/2022 | Q2 2021/2022 | Q3 2021/2022 | 9M 2021/2022 |
|---|---|---|---|---|
| Sales | 350.4 | 458.7 | 428.4 | 1,237.5 |
| EBITDA | 40.2 | 147.0 | 127.7 | 314.9 |
| EBIT | 33.1 | 139.3 | 119.1 | 291.5 |
| EBIT-margin (%) | 9.4 | 30.4 | 27.8 | 23.6 |
| EBT | 32.8 | 139.1 | 151.9 | 291.0 |
| Net result for the period | 22.6 | 97.7 | 79.6 | 199.9 |
| Basic earnings per share (EUR) | 0.35 | 1.55 | 1.26 | 3.16 |
| Operating data | Q1 2021/2022 | Q2 2021/2022 | Q3 2021/2022 | 9M 2021/2022 |
| Production (t) | 209,066 | 223,347 | 206,672 | 639,084 |
| Production (MWh) | 199,877 | 214,841 | 237,183 | 651,901 |
| Utilisation Biodiesel/Bioethanol (%) 1) | 90.9 | 97.1 | 89.9 | 92.6 |
| Utilisation Biomethane (%) 1) | 88.8 | 95.5 | 105.4 | 96.6 |
| Investments in property, plant and equipment | 19.3 | 23.4 | 38.2 | 80.9 |
| Number of employees 2) | 892 | 922 | 958 | 958 |
| Net asset position | 30.09.2021 | 31.12.2021 | 31.03.2022 | 31.03.2022 |
| Net financial assets | 111.5 | 140.5 | 147.5 | 147.5 |
| Equity | 541.7 | 635.1 | 724.0 | 724.0 |
| Equity ratio (%) | 71.8 | 71.3 | 72.5 | 72.5 |
| Balance sheet total | 754.8 | 890.5 | 999.3 | 999.3 |
| Financial position | Q1 2021/2022 | Q2 2021/2022 | Q3 2021/2022 | 9M 2021/2022 |
| Operating cash flow | 18.5 | 76.9 | 64.6 | 160.0 |
| Operating cash flow per share (EUR) | 0.29 | 1.22 | 1.03 | 2.54 |
| Cash and cash equivalents 3) | 141.5 | 170.5 | 177.5 | 177.5 |
1) From July 1, 2021 the annual production capacity of the production plant is as follows:
biodiesel: unchanged 660,000 tonnes; bioethanol: unchanged 260,000 tonnes; biomethane: unchanged 900 GWh
2) At the balance sheet date
3) At the balance sheet date, including cash on segregated accounts
| Quarterly statement for the | |
|---|---|
| period ended March 31, 2022 |
[in EUR million]
Business report and the Group's position
Consolidated profit and loss account
Consolidated cash flow statement
| Profitability | Q1 2020/2021 | Q2 2020/2021 | Q3 2020/2021 | 9M 2020/2021 |
|---|---|---|---|---|
| Sales | 261.4 | 217.7 | 237.8 | 716.9 |
| EBITDA | 53.3 | 27.1 | 32.4 | 112.8 |
| EBIT | 45.6 | 19.4 | 25.4 | 90.4 |
| EBIT-margin (%) | 17.4 | 8.9 | 10.7 | 12.6 |
| EBT | 45.3 | 19.2 | 25.2 | 89.7 |
| Net result for the period | 31.7 | 12.5 | 17.6 | 61.8 |
| Basic earnings per share (EUR) | 0.50 | 0.20 | 0.28 | 0.98 |
| Operating data | Q1 2020/2021 | Q2 2020/2021 | Q3 2020/2021 | 9M 2020/2021 |
| Production (t) | 216,996 | 208,630 | 201,154 | 626,780 |
| Production (MWh) | 216,071 | 198,101 | 180,153 | 594,325 |
| Utilisation Biodiesel/Bioethanol (%) 1) | 94.3 | 90.7 | 87.5 | 90.8 |
| Utilisation Biomethane (%) 1) | 96.0 | 88.0 | 80.1 | 88.0 |
| Investments in property, plant and equipment | 11.5 | 20.8 | 15.5 | 47.8 |
| Number of employees 2) | 754 | 780 | 787 | 787 |
| Net asset position | 30.09.2020 | 31.12.2020 | 31.03.2021 | 31.03.2021 |
| Net financial assets | 86.6 | 79.2 | 54.7 | 54.7 |
| Equity | 419.7 | 433.5 | 453.8 | 453.8 |
| Equity ratio (%) | 74.8 | 75.8 | 76.4 | 76.4 |
| Balance sheet total | 561.0 | 571.6 | 594.3 | 594.3 |
| Financial position | Q1 2020/2021 | Q2 2020/2021 | Q3 2020/2021 | 9M 2020/2021 |
| Operating cash flow | 56.4 | 6.6 | 2.3 | 65.3 |
| Operating cash flow per share (EUR) | 0.90 | 0.10 | 0.04 | 1.04 |
| Cash and cash equivalents 3) | 116.8 | 109.2 | 84.9 | 84.9 |
1) From July 1, 2021 the annual production capacity of the production plant is as follows:
biodiesel: unchanged 660,000 tonnes; bioethanol: unchanged 260,000 tonnes; biomethane: unchanged 900 GWh
2) At the balance sheet date
3) At the balance sheet date, including cash on segregated accounts
[in EUR million]
Business report and the Group's position
Consolidated profit and loss account
Consolidated cash flow statement
| Biodiesel | Q1 2021/2022 | Q2 2021/2022 | Q3 2021/2022 | 9M 2021/2022 |
|---|---|---|---|---|
| Sales | 261.6 | 324.1 | 292.0 | 877.7 |
| EBITDA | 22.2 | 96.1 | 75.3 | 193.6 |
| EBIT | 19.6 | 93.6 | 72.9 | 186.1 |
| Production (t) | 150,007 | 155,185 | 138,988 | 444,180 |
| Utilisation (%) 1) | 90.9 | 94.1 | 84.2 | 89.7 |
| Number of employees 2) | 224 | 219 | 220 | 220 |
| Bioethanol (incl. Biomethane) | Q1 2021/2022 | Q2 2021/2022 | Q3 2021/2022 | 9M 2021/2022 |
|---|---|---|---|---|
| Sales | 86.0 | 131.7 | 133.7 | 351.4 |
| EBITDA | 17.1 | 50.2 | 52.0 | 119.3 |
| EBIT | 13.0 | 45.6 | 46.4 | 105.0 |
| Production (t) | 59,059 | 68,161 | 67,684 | 194,904 |
| Production (MWh) | 199,877 | 214,841 | 237,183 | 651,901 |
| Utilisation Bioethanol (%) 1) | 90.9 | 104.9 | 104.1 | 100.0 |
| Utilisation Biomethane (%) 1) | 88.8 | 95.5 | 105.4 | 96.6 |
| Number of employees 2) | 456 | 477 | 498 | 498 |
| Other | Q1 2021/2022 | Q2 2021/2022 | Q3 2021/2022 | 9M 2021/2022 |
|---|---|---|---|---|
| Sales | 5.4 | 4.7 | 5.3 | 15.4 |
| EBIT | 0.5 | 0.1 | –0.2 | 0.4 |
1) From July 1, 2021 the annual production capacity of the production plant is as follows:
biodiesel: unchanged 660,000 tonnes; bioethanol: unchanged 260,000 tonnes; biomethane: unchanged 900 GWh
2) At the balance sheet date
[in EUR million]
Business report and the Group's position
Consolidated profit and loss account
Consolidated cash flow statement
| Biodiesel | Q1 2020/2021 | Q2 2020/2021 | Q3 2020/2021 | 9M 2020/2021 |
|---|---|---|---|---|
| Sales | 173.0 | 148.2 | 177.3 | 498.5 |
| EBITDA | 13.6 | 13.8 | 28.2 | 55.6 |
| EBIT | 10.9 | 11.0 | 25.5 | 47.4 |
| Production (t) | 154,888 | 152,342 | 147,268 | 454,498 |
| Utilisation (%) 1) | 93.9 | 92.3 | 89.3 | 91.8 |
| Number of employees 2) | 214 | 219 | 219 | 219 |
| Bioethanol (incl. Biomethane) | Q1 2020/2021 | Q2 2020/2021 | Q3 2020/2021 | 9M 2020/2021 |
|---|---|---|---|---|
| Sales | 86.2 | 66.9 | 58.2 | 211.3 |
| EBITDA | 38.8 | 12.6 | 4.0 | 55.4 |
| EBIT | 34.2 | 8.2 | 0.0 | 42.4 |
| Production (t) | 62,108 | 56,288 | 53,887 | 172,283 |
| Production (MWh) | 216,071 | 198,101 | 180,153 | 594,325 |
| Utilisation Bioethanol (%) 1) | 95.6 | 86.6 | 82.9 | 88.4 |
| Utilisation Biomethane (%) 1) | 96.0 | 88.0 | 80.1 | 88.0 |
| Number of employees 2) | 358 | 371 | 378 | 378 |
| Other | Q1 2020/2021 | Q2 2020/2021 | Q3 2020/2021 | 9M 2020/2021 |
|---|---|---|---|---|
| Sales | 4.1 | 4.1 | 4.0 | 12.2 |
| EBIT | 0.5 | 0.1 | 0.0 | 0.6 |
1) From July 1, 2021 the annual production capacity of the production plant is as follows:
biodiesel: unchanged 660,000 tonnes; bioethanol: unchanged 260,000 tonnes; biomethane: unchanged 900 GWh
2) At the balance sheet date
VERBIO AG reports significantly improved results for the first nine months of the financial year 2021/2022 compared to the same period in the previous year. In the third quarter of 2021/2022 the Group has been able to build on the results generated in the second quarter of the financial year. The result (EBITDA) for the quarter just ended was not quite at the record level reported for the preceding quarter, but the EBITDA for the third quarter 2021/2022 alone was 13.2 percent above the accumulated EBITDA for the first nine months of the financial year 2020/2021.
Overall, the Group's revenues increased by 73 percent to EUR 1,237.5 million compared to the previous year (9 M 2020/2021: EUR 716.9 million).
Earnings before interest, taxation, depreciation and amortisation (EBITDA) for the nine-month period amounted to EUR 314.9 million, 179 percent ahead of the comparative period in the previous year (9 M 2020/2021: EUR 112.8 million). The Group result before taxation and interest (EBIT) totalled EUR 291.5 million (9 M 2020/2021: EUR 90.4 million). The Group result before taxation (EBT) totalled EUR 291.0 million (9 M 2020/2021: EUR 89.7 million), and the net result for the period was EUR 199.9 million (9 M 2020/2021: EUR 61.8 million). Based on the result for the period, basic earnings per share amount to EUR 3.16 (9 M 2020/2021: EUR 0.98).
Business report and the Group's position
The balance sheet total at March 31, 2022 amounted to EUR 999.3 million, representing an increase of EUR 320.7 million compared to June 30, 2021 (June 30, 2021: EUR 678.6 million).
The increase on the asset side of the balance sheet included increases in both current and non-current assets. The increase in non-current assets (EUR 436.3 million; June 30, 2021: EUR 312.3 million) primarily reflects the ongoing high levels of investment activity in the current financial year. Changes in current assets primarily reflect the increase in the price levels of raw materials and products sold, with an increase in inventories (EUR 144.1 million; June 30, 2021: EUR 101.5 million) and, in addition, an increase in trade receivables (EUR 111.4 million; June 30, 2021: EUR 69.6 million), as well as in the higher amounts of derivatives recorded to hedge the procurement of raw materials (EUR 100.1 million; June 30, 2021: EUR 44.2 million).
The equity and liabilities side of the balance sheet includes equity of EUR 724.0 million (June 30, 2021: EUR 509.9 million), representing approximately 72.5 percent (June 30, 2021: 75.1 percent) of the balance sheet total. Non-current liabilities are largely unchanged compared to the June 30, 2021 balance sheet date, while current liabilities increased from EUR 123.3 million to EUR 211.4 million. Within this total the primary increases were in trade payables (EUR 94.3 million; June 30, 2021: EUR 45.4 million) and tax liabilities (EUR 58.0 million; June 30, 2021: EUR 19.0 million).
The cash flow from operating activities in the first nine months of the financial year 2021/2022 was also significantly higher than in the previous year, and amounted to EUR 160.0 million (9 M 2020/2021: EUR 65.3 million).
The total cash outflows from investment activities in the first nine months of 2021/2022 were EUR 77.0 million (9 M 2020/2021: EUR 28.1 million) as a result of investments made. In the current financial year, the investments primarily reflect payments made for investments in property, plant and equipment (EUR 77.4 million; 9 M 2020/2021: EUR 48.2 million). In the previous year these were partially offset by cash inflows from the release of term deposits (EUR 20.0 million).
The cash flow from financing activities totalled EUR –17.0 million (9 M 2020/2021: EUR –17.1 million). As in the previous year, cash outflows include EUR 12.6 million from the payment of the dividend for the previous financial year. In both
Consolidated profit and loss account
Consolidated cash flow statement
periods cash outflows include payments for the redemption of lease liabilities of EUR 4.4 million (9 M 2020/2021: EUR 4.4 million).
As a result, cash and cash equivalents increased by EUR 66.9 million in the period July 1, 2021 to March 31, 2022. The balance of cash and cash equivalents reported in the balance sheet at March 31, 2022 amounted to EUR 171.9 million. In addition, VERBIO has further cash resources in the form of lines of credit, the availability of which have been approved for the medium term, totalling EUR 40.0 million.
The Group's bank and loan finance arrangements are offset by cash and cash equivalents, as well as additional cash held in segregated accounts totalling EUR 177.5 million, so that the reported net cash balance at March 31, 2022 amounted to EUR 147.5 million (June 30, 2021: EUR 79.2 million).
The sales and results in the Biodiesel segment in the first nine months of the financial year 2021/2022 were primarily driven by the massive increase in average sales prices, while the comparatively cheap prices for vegetable oils have led to a significant increase in production margins. The capacity utilisation rate for the Group's production equipment remained high at 89.7 percent (9 M 2020/2021: 91.8 percent). In the Bioethanol segment there was a seamless continuation of the trend for production, sales and results seen in the second quarter of the financial year, with production volumes and margins significantly higher than in the third quarter of 2020/2021. The production volume of biodiesel and bioethanol in the period from July 1, 2021 to March 31, 2022 totalled 639,084 tonnes, compared with 626,781 tonnes in the same period in the previous year. In addition, 651.9 GWh of biomethane were produced in the first nine months of the financial year 2021/2022 (9 M 2020/2021: 594.3 GWh), significantly exceeding the level of production in the previous year.
VERBIO makes no change to the earnings forecast published in the ad hoc report issued on April 29, 2022. Accordingly, EBITDA is expected to be around EUR 430 million and the net financial assets balance at the end of the financial year is expected to be approximately EUR 220 million.
There have been no changes to the opportunities and risks presented in the 2021/2022 annual report.
The war in Ukraine does not present a risk to the Group's physical supplies of raw materials. Almost all of our supplies are obtained in Germany and Poland. There are no present risks or discernible potential risks that represent a threat to the ability of the Group to continue as a going concern.
for the period July 1, 2021 to March 31, 2022
Consolidated profit and loss account
Business report and the Group's position
Consolidated profit and loss account
Consolidated cash flow statement
| EUR (thousands) | Q3 2021/2022 | Q3 2020/2021 | 9M 2021/2022 | 9M 2020/2021 | |
|---|---|---|---|---|---|
| 1. | Revenue (including energy taxes collected) | 428,688 | 237,920 | 1,238,246 | 718,016 |
| less: energy taxes | –314 | –162 | –725 | –1,164 | |
| Revenue | 428,374 | 237,758 | 1,237,521 | 716,852 | |
| 2. | Change in unfinished and finished goods | 21,848 | –1,001 | 29,483 | 11,070 |
| 3. | Capitalised production of own plant and equipment | 1,537 | 410 | 3,112 | 1,075 |
| 4. | Other operating income | 5,509 | 2,597 | 15,970 | 9,878 |
| 5. | Cost of materials | –302,537 | –176,956 | –850,654 | –548,879 |
| 6. | Personnel expenses | –19,199 | –12,941 | –49,392 | –37,097 |
| 7. | Depreciation and amortisation | –8,566 | –7,012 | –23,415 | –22,416 |
| 8. | Other operating expenses | –16,773 | –10,456 | –43,122 | –33,219 |
| 9. | Result from commodity forward contracts | 8,960 | –7,020 | –27,987 | –6,845 |
| 10. | Operating result | 119,153 | 25,379 | 291,516 | 90,419 |
| 11. | Interest income | 124 | 76 | 192 | 116 |
| 12. | Interest expense | –125 | –258 | –671 | –847 |
| 13. | Financial result | –1 | –182 | –479 | –731 |
| 14. | Result before tax | 119,152 | 25,197 | 291,037 | 89,688 |
| 15. | Income tax expense | –39,601 | –7,585 | –91,167 | –27,915 |
| 16. | Net result for the period | 79,551 | 17,612 | 199,870 | 61,773 |
| Result attributable to shareholders of the parent company | 79,551 | 17,562 | 199,766 | 61,521 | |
| Result attributable to non-controlling interests | –21 | 50 | 104 | 252 | |
| Result per share (basic and diluted) | 1.26 | 0.28 | 3.16 | 0.98 |
| Quarterly statement for the |
|---|
| period ended March 31, 2022 |
Business report and the Group's position
Consolidated profit and loss account
Consolidated balance sheet
Consolidated cash flow statement
at March 31, 2022
| EUR (thousands) | 31.03.2022 | 30.06.2021 |
|---|---|---|
| Assets | ||
| A. Non-current assets |
||
| I. Intangible assets |
830 | 602 |
| II. Property, plant and equipment |
358,973 | 290,554 |
| III. Right-of-use assets under leasing arrangements |
17,565 | 16,228 |
| IV. Financial assets |
2,814 | 2,816 |
| V. Other assets |
54,048 | 0 |
| VI. Deferred tax assets |
2,058 | 2,077 |
| Total non-current assets | 436,288 | 312,277 |
| B. Current assets |
||
| I. Inventories |
144,075 | 101,463 |
| II. Trade receivables |
111,436 | 69,565 |
| III. Derivatives |
100,080 | 44,172 |
| IV. Other short-term financial assets |
14,010 | 28,506 |
| V. Tax refunds |
73 | 73 |
| VI. Other assets |
21,371 | 17,540 |
| VII. Cash and cash equivalents |
171,948 | 105,025 |
| Total current assets | 562,993 | 366,344 |
| Total assets | 999,281 | 678,621 |
Business report and the Group's position
Consolidated profit and loss account
Consolidated cash flow statement
| EUR (thousands) | 31.03.2022 | 30.06.2021 |
|---|---|---|
| Liabilities and equity | ||
| A. Equity |
||
| I. Share capital |
63,184 | 63,184 |
| II. Additional paid-in capital |
499,480 | 495,692 |
| III. Other reserves |
46,817 | 33,680 |
| IV. Retained earnings |
105,406 | –81,727 |
| V. Reserve for translation adjustments |
6,965 | –2,980 |
| Total equity, excluding non-controlling interests | 721,852 | 507,849 |
| VI. Non-controlling interests |
2,127 | 2,023 |
| Total equity | 723,979 | 509,872 |
| B. Non-current liabilities |
||
| I. Bank loans and other loans |
30,000 | 30,000 |
| II. Lease liabilities |
14,593 | 11,125 |
| III. Provisions |
131 | 131 |
| IV. Deferred investment grants and subsidies |
1,623 | 2,172 |
| V. Other non-current liabilities |
222 | 222 |
| VI. Deferred taxes |
17,296 | 1,806 |
| Total non-current liabilities | 63,865 | 45,456 |
| C. Current liabilities |
||
| I. Lease liabilities |
3,269 | 5,356 |
| II. Trade payables |
94,275 | 45,382 |
| III. Derivatives |
28,260 | 22,508 |
| IV. Other current financial liabilities |
16,135 | 11,235 |
| V. Tax liabilities |
57,970 | 18,993 |
| VI. Provisions |
3,281 | 9,656 |
| VII. Deferred investment grants and subsidies |
837 | 859 |
| VIII. Other current liabilities |
7,410 | 9,304 |
| Total current liabilities | 211,437 | 123,293 |
| Total equity and liabilities | 999,281 | 678,621 |
Business report and the Group's position
Consolidated profit and loss account
Consolidated cash flow statement
for the period July 1, 2021 to March 31, 2022
| EUR (thousands) | 9M 2021/2022 | 9M 2020/2021 |
|---|---|---|
| Net result for the period | 199,870 | 61,773 |
| Income taxes | 91,167 | 27,915 |
| Interest result | 479 | 731 |
| Depreciation and amortisation | 23,415 | 22,416 |
| Non-cash income and expenses | 1,022 | 532 |
| Non-cash expenses for share-based remuneration | 4,089 | 0 |
| Gains on disposal of property, plant and equipment | –258 | –119 |
| Release of deferred investment grants and subsidies | –570 | –759 |
| Non-cash changes in derivative financial instruments | –19,839 | 3,261 |
| Increase in inventories | –42,612 | –11,862 |
| Increase in trade receivables | –41,870 | –4,730 |
| Increase (previous year: decrease) in other assets and other current financial assets | –48,446 | 1,230 |
| Decrease (previous year: increase) in provisions | –6,374 | 10,300 |
| Increase (previous year: decrease) in trade payables | 45,902 | –10,210 |
| Increase (previous year: decrease) in other current financial and non-financial liabilities | 3,013 | –77 |
| Interest paid | –456 | –644 |
| Interest received | 192 | 116 |
| Income taxes paid | –48,767 | –34,561 |
| Cash flows from operating activities | 159,957 | 65,312 |
| Quarterly statement for the | EUR (thousands) | 9M 2021/2022 | 9M 2020/2021 |
|---|---|---|---|
| period ended March 31, 2022 | Cash inflows from term deposits | 0 | 20,000 |
| Group key figures | Cash outflows for acquisition of intangible assets | –389 | –116 |
| Segment key figures | Cash outflows for acquisition of property, plant and equipment | –77,373 | –48,208 |
| Proceeds from disposal of property, plant and equipment | 758 | 268 | |
| Business report and the Group's position |
Cash flows from investing activities | –77,004 | –28,056 |
| Dividends paid | –12,637 | –12,600 | |
| Consolidated profit and loss account |
Payments for the redemption of financial liabilities | 0 | –64 |
| Payment of lease liabilities | –4,353 | –4,427 | |
| Consolidated balance sheet | Cash flows from financing activities | –16,990 | –17,091 |
| Consolidated cash flow statement |
Change in cash funds resulting from business transactions | 65,963 | 20,165 |
| Change in cash funds due to effects of exchange rates | 960 | –467 | |
| Financial calendar | Cash funds at beginning of year | 105,025 | 53,885 |
| Cash funds at end of year | 171,948 | 73,583 | |
| Cash funds at year end comprise the following: | |||
| Cash and cash equivalents | 171,948 | 73,583 | |
| Cash funds at end of year | 171,948 | 117,233 |
| Quarterly statement for the | |
|---|---|
| period ended March 31, 2022 |
| Business report and the | |
|---|---|
| Group's position |
Consolidated profit and loss account
Consolidated cash flow statement
| September 27, 2022 | Publication of the annual report 2021/2022 Analysts' and annual financial press conference |
|---|---|
| November 10, 2022 | Publication of quarterly statement 2022/2023 for the period ended September 30, 2022 (July 2022 to September 2022) |
| February 3, 2023 | Annual general meeting 2023 |
| February 9, 2023 | Publication of the half-yearly interim report 2022/2023 (July 2022 to December 2022), Analyst's conference |
| May 11, 2023 | Publication of quarterly statement 2022/2023 for the period ended March 31, 2023 (July 2022 to March 2023) |
| September 26, 2023 | Publication of the annual report 2022/2023 Analysts' and annual financial press conference |
VERBIO Vereinigte BioEnergie AG
VERBIO Vereinigte BioEnergie AG Ritterstraße 23 (Oelßner's Hof) 04109 Leipzig Telefon: +49 341 308530-0 www.verbio.de
This quarterly statement includes various statements concerning forecasts, expectations and information that relate to the future development of the VERBIO Group and VERBIO Vereinigte BioEnergie AG. These statements are based on assumptions and estimates and may be associated with known and unknown risks and uncertainties. Actual developments and results, as well as the financial and asset situation, may therefore differ substantially from the expectations and assumptions stated. Such differences may be due, among other things, to market fluctuations, changes in worldwide market prices for raw materials as well as financial markets and exchange rates, changes in national and international laws and directives, or fundamental changes in the economic and political climate. VERBIO does not intend to and does not undertake an obligation to update or revise any forward-looking statements to adapt them to events or developments after the publication of this quarterly statement.
This quarterly statement is published in German (original version) and in English (non-binding translation). It is available for download at http://www.verbio.de in both languages.
We will be delighted to send you additional information about VERBIO Vereinigte BioEnergie AG on request at no charge. Telephone: +49 341 308530-0 E-Mail: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.